Press Releases
DGR Technology Platform for Engineering Proteins Advanced in Publication by AvidBiotics Collaborators
South San Francisco, CA (December 15, 2011): AvidBiotics today announced the publication of new findings in PLoS Genetics that could enable genetic Continue»
AvidBiotics’ Targeted Antibacterial Proteins Show Potential to Address Food-Borne Bacterial Infections, Provide Antibiotic Alternative
New Publication Demonstrates Ability of Avidocin™ Proteins to Prevent and Treat E. coli O157 Diarrhea in Animal Study Continue»
Two New Grants for Targeted Antibacterial Proteins
South San Francisco, CA: AvidBiotics today announced the receipt of two new grants totaling $1 million dollars Continue»
Articles
One-on-One with Jim Knighton of AvidBiotics
By: Ron Leuty |
Source: San Francisco Business Times
AvidBiotics Corp. started work in human therapeutics several years ago, but it’s really taken a liking to food. Continue»
AvidBiotics: Punching Holes In Bacterial Resistance
By: Suzanne Elvidge |
Source: Life Science Leader
Bacterial infection is a huge and growing medical burden worldwide — the Centers for Disease Control and Prevention estimates Continue»
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body
By: Luke Timmerman |
Source: XConomy.com
Dave Martin is one of the people in biotech who has truly seen it all. In the ’80s, the industry’s early days, he was head of R&D at Genentech. Continue»